I am a connoisseur of retro horror. I’ve been chasing the dragon since I first saw Halloween decades ago. My fondness for the great babysitter-in-peril pictures of years past makes me the target ...

The Controller General of Patents, Designs and Trademarks (CGPDTM), the Indian Patent Office, has annulled the patent granted to Novartis for its cardiac drug Vymada, also sold internationally as ...

As four of the nation’s most accurate pollsters, we recently formed the National Association of Independent Pollsters. The four founding member organizations participated in a joint national survey of ...

Minecraft has come a long way since its initial inception, with players all around the world jumping in every day. From embarking on new Survival Worlds to racing towards the End, to trying their luck ...

After 14 years, Apple has quietly retired Launchpad, the Mac’s iPhone-style app launcher, with the release of macOS Tahoe. In its place is a new feature called simply Apps, which borrows some of ...

It’s never been easier to go somewhere, but at the same time, it’s also never been harder to say why. As the most well-travelled generation in history, we can effortlessly book a trip to the other ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

Despite covering 70 crore citizens under Ayushman Bharat and reducing out-of-pocket spending, India’s universal healthcare dream remains elusive. At ETHealthworld’s 5th Healthcare Leaders Summit, ...

Faced with the prospect of tariffs on imported medicines threatened by the Trump administration, Indian drugmaker Hikma has said it will spend $1 billion to expand its manufacturing and R&D operations ...

Obesity affects approximately 1.3 billion people worldwide and contributes to a wide range of chronic diseases, from metabolic and cardiovascular disorders to cancer. Its rising prevalence and ...

“Amgen’s takeaway is simple yet profound: The current system is working, and innovation is benefiting actual patients.” The ongoing policy debate about pharmaceutical and biologic patents has been ...